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Introduction
A number of different poxviruses can infect both people 
and domestic animals; with cowpox being the best 
described and most commonly encountered poxvirus 
infection of cats. Cowpox virus (CPxV) is a member of 
Orthopoxviridae family and is endemic in Northern 
Europe and western areas of the Soviet Union.1
The usual route of infection is via skin inoculation 
from infected rodent bites, typically voles, or rarely via 
oronasal infection.2 Reflective of this transmission route, 
skin lesions are commonly found on the head, neck and 
forelimbs. However, systemic illness such as pyrexia, 
anorexia, lethargy and/or pneumonia can occur during 
the viraemic phase and is usually associated with 
immune dysfunction and death.3,4
It is important that clinicians recognise the signs of 
potential CPxV infection and perform appropriate diag-
nostics early. A significant factor contributing to the 
prognosis of CPxV infection in cats is the speed at which 
appropriate therapy is instituted, so rapid recognition is 
crucial. Cytological analysis of the affected organs can be 
misleading, with the secondarily dysplastic cells having 
the potential to mimic neoplasma. Instead, electron 
microscopy, virus isolation and PCR of tissues (includ-
ing skin scabs, bronchoalveolar or pleural fluid, or pul-
monary aspirates) are the easiest ways to confirm the 
diagnosis.5 Serum assays (including virus neutralisation, 
haemagglutination inhibition, complement fixation and 
ELISA) can be utilised to detect a humoral response to 
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orthopoxvirus, although a rising titre is required to sup-
port active infection.4
Treatment includes broad-spectrum antibiotics to 
control secondary bacterial infection and recombinant 
feline interferon omega (rFeIFN-ω) to modulate the 
immune response. Antiviral drugs, such as famciclovir, 
commonly used for the treatment of feline herpesvirus 
(FeHV-1) disease in cats,6 could also be considered; how-
ever, their efficacy against CPxV is unknown.
Our previous case series detailed cats that had pul-
monary CPxV-infection, complicated by concomitant 
infection with FeHV-1, Bordetella bronchiseptica and/or 
Mycoplasma species.4 The cases described herein have 
novel findings which have not previously been described 
in relation to this infection, including central nervous 
system (CNS) involvement and presentation as a laryn-
geal mass.
Case series description
Case 1
A 6-year-old, neutered male domestic shorthair (DSH) cat 
was seen at the VRCC for investigation and management 
of dysphonia and intermittent inspiratory stridor of 17 
days’ duration. The cat was vaccinated against feline pan-
leukopenia virus, feline calicivirus and FeHV-1, lived in a 
rural area and was reported to be a keen hunter. Routine 
haematology and serum biochemistry were unremarka-
ble. Serum was negative for feline leukaemia virus (FeLV) 
p27 antigen, feline immunodeficiency virus (FIV) anti-
bodies and feline coronavirus antibodies. Under general 
anaesthesia, full oropharyngeal and laryngeal examina-
tion identified laryngeal oedema with normal function. 
The cat was discharged with amoxicillin–clavulanic acid 
(Clavaseptin [Vetoquinol] 15 mg/kg PO q12h).
A week later, the cat re-presented with inspiratory 
dyspnoea and pronounced inspiratory stridor. No other 
abnormalities were found on physical examination, 
except for sinus bradycardia (heart rate ranging between 
84 and 120 bpm). An atropine response test was positive, 
indicating that the bradycardia was likely due to high 
vagal tone. Neither skin lesions nor pyrexia were 
present.
Full oropharyngeal and laryngeal examination was 
repeated and identified a 1 cm right-sided para-laryn-
geal mass and oedema affecting the right arytenoid pro-
cess. Biopsy samples were obtained for histopathology, 
and identified a cluster of epithelial cells with intracyto-
plasmic eosinophilic inclusion bodies, as well as an 
inflammatory infiltrate (Figure 1). Quantitative PCR per-
formed on scrolls from the formalin-fixed biopsies con-
firmed the presence of CPxV DNA within the sections. 
Thoracic radiographs and abdominal ultrasound 
excluded the presence of disseminated disease.
The cat was given supportive care, including oxygen 
and compound sodium lactate (Hartmann’s solution, 2 
ml/kg/h IV). Feline rFeIFN-ω (Virbagen Omega; Virbac 
[1 MU/kg SC q24h for 3 days]), prednisolone (Prednicare 
[Animal Care] 0.5 mg/kg PO q24h), marbofloxacin 
(Marbocyl [Vetoquinol] 2 mg/kg IV q24h) and famciclo-
vir (Famvir [Novartis] 62.5 mg PO q12h) were also 
administered. Following clinical improvement the cat 
was discharged.
Fourteen days after first presentation, full oropharyn-
geal and laryngeal examination revealed the lesion had 
grossly resolved, as had the previously reported clinical 
signs. A year after diagnosis, the cat was clinically well 
with no further episodes of stridor or dysphonia.
Case 2
A 4-year-10-month-old, neutered male DSH cat pre-
sented to its primary veterinary practice with a history 
of focal superficial ulceration with associated oedema 
and swelling of the subcutaneous adipose tissue in the 
caudal mammary region; the cat had a temperature of 
39.0ºC. It had a history of being an avid hunter and was 
overweight at the time, with a body condition score of 
7/9. The cat was treated with cefovecin (Convenia 
[Zoetis] 8 mg/kg SC) and oral meloxicam (Metacam 
[Boehringer Ingelheim] 0.05 mg/kg PO q24h).
Three days later the cat was re-presented. There had 
been no response to the previous treatment with the 
lesion worsening in appearance, which now had a wid-
ened area of ulceration, pronounced thickening and 
marked oedema of the underlying subcutaneous tissue. 
Oral clindamycin (Antirobe [Zoetis] 5.5 mg/kg q12h) 
was commenced in addition to the current medications.
A further 2 days later, the area of ulceration affecting 
the ventral abdomen had progressed to a necrotic eschar 
(Figure 2), with a concurrent increase in lethargy and 
Figure 1 Case 1: the mucosal epithelium is extensively 
ulcerated with widespread accumulations of neutrophils and 
proteinaceous exudate. Where intact, the majority of mucosal 
epithelial cells contain one or more large distinct oval-to-round 
brightly eosinophilic intracytoplasmic inclusion bodies (arrows)
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discomfort. There were also multiple small raised nod-
ules surrounding the central necrotic area, and crusting 
papules and nodules around the head and neck 
(Figure 3). Buprenorphine was administered (Vetergesic 
[Ceva] 20 μg/kg IV q8h) to provide analgesia.
The following day, 7 days after initial presentation, 
biopsies of the affected areas were taken. Biopsies from 
the head and ventral lesions identified locally extensive 
ulceration, covered with a thick layer of necrotic tissue. 
There was also extensive epidermal and adnexal necro-
sis with follicular and epidermal keratinocytes contain-
ing large, eosinophilic intracytoplasmic inclusion bodies, 
consistent with viral inclusion bodies. Bacteriology 
swabs taken from the lesions did not yield any bacterial 
growth.
Thoracic radiographs were unremarkable, with no 
evidence of pulmonary changes. Prior to biopsy results 
being obtained, a presumptive diagnosis of poxvirus 
was made and treatment with intravenous rFeIFN-ω 
(Virbagen Omega [Virbac] 1MU/kg SC q24h for 3 days) 
was commenced.
On day 9, some improvement had been seen in the 
cat’s demeanour with a return of appetite. The lesions 
affecting the head had not progressed and no new lesions 
were noted. The central necrotic region remained static, 
with the subcutaneous swelling becoming softer on pal-
pation. The cat was discharged later that day; the owner 
was informed of the zoonotic potential and appropriate 
measures to take.
The cat re-presented on day 12, with its appetite hav-
ing reduced, resulting in difficulty administering oral 
medications. The cat was lethargic again. The cat was 
given intravenous rFeIFN-ω (as above) for a further 3 
days. However, by day 14, de novo nodular lesions had 
developed on the neck, head and thoracic limbs. The 
ventrally necrotic region began expanding in size and 
the small raised papules were becoming more evident 
again. FeLV and FIV status were confirmed as negative, 
using a bidirectional flow ELISA Snap test.
The following day, the cat became progressively 
obtunded and developed anisocoria. Given the lim-
ited response to treatment, and progression of clinical 
signs with CNS involvement, the owners elected for 
euthanasia.
A necropsy was performed at the Royal (Dick) School 
of Veterinary Studies. The eschar lesion was found to 
extend full thickness through the dermis (Figure 4). 
Quantitative PCR for CPxV was performed on this tissue, 
with high amounts of viral DNA identified. Histopathology 
of this lesion identified a complete loss of the epidermis, 
and expansion of the dermis with an inflammatory infil-
trate dominated by macrophages, neutrophils (mature 
and degenerate) and occasional lymphocytes. There were 
extensive areas of cell necrosis with well-demarcated, 
eosinophilic, intracytoplasmic inclusion bodies (Figure 5). 
The post-mortem examination also showed multifocal to 
coalescing, raised, alopecic and erythematous lesions 
affecting all four limbs. The lungs had multifocal areas of 
consolidation, with small quantities of white foam within 
the terminal bronchi. The pericardium was thickened 
with a moderately increased amount of pericardial fluid. 
As neurological changes were evident clinically, histopa-
thology of the cerebral hemispheres and cerebellum was 
performed. There was marked microgliosis of all areas, 
with many having abundant cytoplasm within them. 
Occasionally eosinophilic intracytoplasmic inclusion bod-
ies were identified (Figure 5).
The findings were consistent with multi-systemic dis-
ease with terminal neurological involvement, which has 
not been reported previously with CPxV infection.
Figure 2 Case 2: this image depicts the necrotic eschar 
which became apparent on day 5
Figure 3 Case 2: this image depicts the lesions noted on 
the head, which are typical of cowpox virus dermatopathy. 
As some of these had been biopsied prior to the photograph 
having been taken, there are sutures present
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Discussion
These cases provide novel findings in that CPxV infec-
tion can infect and cause disease within the CNS, or pre-
sent solely as a laryngeal mass, with the associated 
clinical signs, but no concomitant cutaneous or pulmo-
nary pathology. As more cases of CPxV infection are 
published it is becoming apparent that this infection in 
cats can produce a number of differing presentations, 
and it should be considered a valid differential diagnosis 
in patients with a number of presentations.
Case 1 identified a novel presentation of CPxV infec-
tion, as a localised, focal form of disease affecting only 
the larynx and para-laryngeal area. This cat responded 
well to treatment and had no evidence of pulmonary 
pathology during investigations. This case shows that 
CPxV infection should be considered as a differential 
diagnosis in cases of focal disease of the respiratory 
tract, as well as the more commonly recognised cutane-
ous and lower respiratory presentations. Reported clini-
cal signs for CPxV infection are typically skin lesions 
(commonly found on the head, neck and forelimbs) and, 
rarely, fatal necrotising pneumonia.4,7–10 Interestingly, 
no skin lesions were evident in this case – this has previ-
ously been described in a single cat with CPxV pneumo-
nia.11 The lack of cutaneous pathology may reflect the 
fact that, in rare cases, the virus can be transmitted by 
the oronasal route.12
Case 2 had classic dermatological signs, with no clini-
cal or imaging findings consistent with pulmonary dis-
ease (although these were apparent on post-mortem 
evaluation). This cat began to display neurological signs, 
consistent of sensorium changes, as well as anisocoria, 
likely secondary to viral infection of the CNS (with con-
sistent findings on histopathology). This has not been 
reported in previous case series. From this case we now 
know that CPxV infection should remain a differential in 
cats with neurological signs, particularly if accompanied 
with dermatological and/or respiratory involvement.
Only case 2 presented with significant cutaneous 
pathology. These cases show the importance of taking a 
full history, as finding a cat with a history of outdoor 
access and a tendency to hunt rodents, alongside acute 
clinical signs that included coughing, pyrexia, and/or 
cutaneous changes, should suggest that CPxV infection 
should be considered as a potential differential diagno-
sis. It is essential that CPxV is considered as a differential 
diagnosis, and investigated, via cytology, histopathol-
ogy and/or PCR of pulmonary aspirates or cutaneous 
lesions, in order that this potentially serious zoonotic 
infection can be identified at an early stage, the case 
treated appropriately, and with all necessary precautions 
taken.
Conclusions
The importance of CPxV-induced disease in cats is gain-
ing increased recognition. In the autumn in which this 
manuscript was being prepared, the authors became 
aware of an increase in prevalence of CPxV in the UK, 
with particularly virulent characteristics.13
With cutaneous and respiratory signs occurring rela-
tively frequently with CPxV infection, it is important 
that clinicians recognise these signs, consider this 
Figure 5 Case 2: histopathology of the cerebrum, stained 
with haematoxylin and eosin (× 40 magnification). There are 
microglia, with large numbers having abundant cytoplasm. 
There are also eosinophilic inclusion bodies found within the 
cytoplasm of the microglia (arrows), consistent with CPxV 
infection
Figure 4 Case 2: image obtained post mortem demonstrating 
the full extent of the eschar, extending the entire layer of the 
dermis
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potential differential diagnosis, perform appropriate 
diagnostics and commence appropriate management. 
This case series emphasises the need to consider CPxV in 
circumstances where there are not the classical signs, or 
where there is atypical body system involvement, be it 
neurological or upper respiratory.
To our knowledge, this is the first case series to 
describe laryngeal and neurological CPxV infections in 
the domestic cat. As we have identified, CPxV can cause 
focal laryngeal disease and as such should be considered 
as a zoonotic differential diagnosis for clinical signs per-
taining to the upper respiratory tract.
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